Shijiazhuang Yiling Pharmaceutical Co Ltd Class A 002603
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 19.68
- Day Range
- CNY 19.40–20.05
- 52-Week Range
- CNY 17.80–30.78
- Bid/Ask
- CNY 19.95 / CNY 19.96
- Market Cap
- CNY 33.33 Bil
- Volume/Avg
- 22.5 Mil / 13.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 11.73
- Price/Sales
- 3.69
- Dividend Yield (Trailing)
- 2.54%
- Dividend Yield (Forward)
- 2.54%
- Total Yield
- 2.54%
Company Profile
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 13,958
- Website
- http://www.yiling.cn/
Comparables
Valuation
|
Metric
|
002603
|
002826
|
603367
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.73 | 36.59 | 16.02 |
Price/Book Value | 2.80 | 2.32 | 1.27 |
Price/Sales | 3.69 | 2.59 | 1.68 |
Price/Cash Flow | — | 8.99 | 12.58 |
Price/Earnings
002603
002826
603367
Financial Strength
|
Metric
|
002603
|
002826
|
603367
|
|---|---|---|---|
Quick Ratio | 1.03 | 2.58 | 2.84 |
Current Ratio | 1.55 | 2.85 | 3.62 |
Interest Coverage | 14.54 | 51.03 | 84.52 |
Quick Ratio
002603
002826
603367
Profitability
|
Metric
|
002603
|
002826
|
603367
|
|---|---|---|---|
Return on Assets (Normalized) | 2.16% | 4.73% | 6.25% |
Return on Equity (Normalized) | 3.22% | 6.14% | 7.93% |
Return on Invested Capital (Normalized) | 3.00% | 5.70% | 7.24% |
Return on Assets
002603
002826
603367
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Pqxqdflxg | Ljzt | $76.6 Bil | |
MKKGY
| Merck KGaA ADR | Njgbklqxb | Mrldsnb | $72.3 Bil | |
HLN
| Haleon PLC ADR | Qygcpjbs | Jtkc | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wqfzylbs | Kspww | $18.3 Bil | |
VTRS
| Viatris Inc | Zxmztsps | Vxwvg | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hpjzhll | Ggb | $11.8 Bil | |
CTLT
| Catalent Inc | Mzbyyfws | Zspxwfg | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Hntksvb | Nysl | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Mtbztggr | Vpr | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fgckxmn | Hmcrspc | $3.5 Bil |